These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34992436)

  • 21. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

  • 23. ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer.
    Zhang J; Wang H; Yuan C; Wu J; Xu J; Chen S; Zhang C; He Y
    Front Cell Dev Biol; 2022; 10():808212. PubMed ID: 35399517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer.
    Wang J; Liu D; Xie Y
    Front Oncol; 2023; 13():1142017. PubMed ID: 37469414
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
    Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
    World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database.
    Liu B; Chen L; Huang H; Huang H; Jin H; Fu C
    Dis Markers; 2022; 2022():7803642. PubMed ID: 35756485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
    Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
    Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
    [No Abstract]   [Full Text] [Related]  

  • 29. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
    Zhu H; Wang G; Zhu H; Xu A
    J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
    [No Abstract]   [Full Text] [Related]  

  • 30. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells.
    Ren S; Chen M; Chen Y; Ding K
    Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis.
    Li M; Zhou C
    Transl Cancer Res; 2021 Jun; 10(6):2663-2677. PubMed ID: 35116579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Fang F; Zhang T; Lei H; Shen X
    PeerJ; 2023; 11():e15613. PubMed ID: 37404478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
    Li X; He J; Yu M; Zhang W; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic analysis of
    Jiang Y; Wang X; Li L; He J; Jin Q; Long D; Liu C; Zhou W; Liu K
    Front Genet; 2022; 13():926943. PubMed ID: 35991552
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.
    Liu B; Zhang Y; Suo J
    Front Genet; 2021; 12():689585. PubMed ID: 34220962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
    Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y
    Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer.
    Gong Z; Zheng Q; Li B; Wang H; Chen H; Lin S
    J Cancer; 2024; 15(10):2994-3009. PubMed ID: 38706903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.